Skip to content
Home › 13F recaps › Q3 2026 › MRNA

Which funds bought or sold MRNA in Q3 2026?

Moderna Inc. 11 funds bought, 9 sold, out of 109 tracked funds that have filed for Q3 2026. Among active managers, the estimated net flow was −$261M.

Holdings as of Sep 30, 2026 (Q3 2026)13F deadline Nov 16, 2026 (45 days after quarter end)

PostLinkedIn
Who bought and who sold MRNA, by estimated dollars
◀ SoldBought ▶

Top 10 each side. NEW = opened a position, OUT = sold the whole position.

Bought (11)

FundChangeEst. $Now
Fidelity
Asset manager
Added+13.7%+$1.4B$11.4B
Millennium
Quant & multi-strategy
Added+787.8%+$665M$750M
Susquehanna
Quant & multi-strategy
Added+577.2%+$398M$467M
QRT
Quant & multi-strategy
Added+222.3%+$388M$563M
JPMorgan
Bank & broker
Added+206.2%+$354M$526M
Goldman Sachs
Bank & broker
Added+27.2%+$245M$1.1B
Wellington
Asset manager
Added+50.9%+$241M$716M
Vanguard Capital
Index giant
Added+3%+$136M$4.6B
Geode
Index giant
Added+5.5%+$103M$2.0B
Holocene
Hedge fund
New+$97M$97M
ExodusPoint
Quant & multi-strategy
New+$63M$63M

Sold (9)

FundChangeEst. $Now
Baillie Gifford
Growth / crossover
Trimmed-37.2%−$1.3B$2.2B
Two Sigma
Quant & multi-strategy
Trimmed-93.5%−$1.3B$90M
Morgan Stanley
Bank & broker
Trimmed-36.9%−$678M$1.2B
Invesco
Asset manager
Trimmed-54.6%−$608M$505M
BlackRock
Index giant
Trimmed-9.2%−$540M$5.4B
Schwab
Index giant
Trimmed-33.5%−$312M$619M
RBC
Bank & broker
Trimmed-54.2%−$99M$83M
Legal & General
Asset manager
Trimmed-20.4%−$35M$135M
CalPERS
Sovereign & pension
Trimmed-20.7%−$20M$76M

Source: SEC EDGAR Form 13F-HR for each fund, holdings as of Sep 30, 2026. Shares only (options excluded). Estimated $ = change in shares × quarter-end price. Funds may have traded since. Methodology. Not investment advice.

Most bought in Q3 2026 → · Most sold →

Weekly digest · free

13F filings and guru moves, in one short email

A Sunday digest of what famous investors said and filed this week, plus an alert when someone changes stance. Free, no spam, unsubscribe anytime.